Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine

Journal of Alzheimer's Disease : JAD
Ester AsoIsidre Ferrer

Abstract

The endogenous cannabinoid system represents a promising therapeutic target to modify neurodegenerative pathways linked to Alzheimer's disease (AD). The aim of the present study was to evaluate the specific contribution of CB2 receptor to the progression of AD-like pathology and its role in the positive effect of a cannabis-based medicine (1:1 combination of Δ9-tetrahidrocannabinol and cannabidiol) previously demonstrated to be beneficial in the AβPP/PS1 transgenic model of the disease. A new mouse strain was generated by crossing AβPP/PS1 transgenic mice with CB2 knockout mice. Results show that lack of CB2 exacerbates cortical Aβ deposition and increases the levels of soluble Aβ40. However, CB2 receptor deficiency does not affect the viability of AβPP/PS1 mice, does not accelerate their memory impairment, does not modify tau hyperphosphorylation in dystrophic neurites associated to Aβ plaques, and does not attenuate the positive cognitive effect induced by the cannabis-based medicine in these animals. These findings suggest a minor role for the CB2 receptor in the therapeutic effect of the cannabis-based medicine in AβPP/PS1 mice, but also constitute evidence of a link between CB2 receptor and Aβ processing.

References

May 24, 2000·European Journal of Pharmacology·N E BuckleyA Zimmer
Feb 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Belén G RamírezMaría L de Ceballos
May 30, 2006·Cellular and Molecular Life Sciences : CMLS·M van der SteltV Di Marzo
Jun 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·Giuseppe EspositoLuca Steardo
Oct 16, 2007·British Journal of Pharmacology·C BenitoJ Romero
Nov 27, 2007·British Journal of Pharmacology·G A CabralF Marciano-Cabral
Apr 10, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Maria Teresa ViscomiMauro Maccarrone
Jul 2, 2010·British Journal of Pharmacology·Brady K Atwood, Ken Mackie
Feb 26, 2011·Molecular Pharmacology·Ana María Martín-MorenoMaría L de Ceballos
Mar 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ming JinDennis J Selkoe
Jul 14, 2011·British Journal of Pharmacology·Ethan B Russo
Mar 28, 2012·Journal of Alzheimer's Disease : JAD·Ester AsoIsidro Ferrer
Apr 26, 2012·The Journal of Biological Chemistry·Lucía CallénPeter J McCormick
Jul 6, 2012·Neurobiology of Aging·Maite SolasMaria J Ramirez
Jul 17, 2012·Neurobiology of Aging·Jiang WuMohamed Naguib
Sep 22, 2012·Science·Dennis J Selkoe
Mar 13, 2013·Journal of Alzheimer's Disease : JAD·Maria J CasarejosMaria A Mena
Mar 22, 2013·Journal of Alzheimer's Disease : JAD·Ester AsoIsidro Ferrer
Jun 26, 2013·Neuropharmacology·María S García-GutiérrezJorge Manzanares
Jul 16, 2014·Journal of Alzheimer's Disease : JAD·Chuanhai CaoJianfeng Cai
Aug 12, 2014·Molecular Pharmacology·Amey Dhopeshwarkar, Ken Mackie
Aug 16, 2014·Journal of Alzheimer's Disease : JAD·Ester AsoIsidro Ferrer
Nov 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hai-Ying ZhangZheng-Xiong Xi
Dec 3, 2014·Neurobiology of Aging·Anne-Caroline SchmöleAndreas Zimmer

❮ Previous
Next ❯

Citations

Jun 16, 2016·Frontiers in Neuroscience·Ester Aso, Isidro Ferrer
Jun 14, 2017·Journal of Neurochemistry·Balapal S BasavarajappaShivakumar Subbanna
Jan 29, 2017·Journal of Molecular Cell Biology·Christopher Lipina, Harinder S Hundal
Jun 6, 2018·Journal of Alzheimer's Disease : JAD·Anne-Caroline SchmöleAndreas Zimmer
May 26, 2018·Journal of Neuroinflammation·Alicia LópezJulián Romero
Jul 4, 2018·International Journal of Molecular Sciences·Yasuhisa Ano, Hiroyuki Nakayama
Jul 12, 2018·Journal of Alzheimer's Disease : JAD·Lin WangXin-Wen Zhou
Jun 27, 2019·Expert Review of Neurotherapeutics·Graham PowellA J Larner
Aug 15, 2019·Neurotoxicology·Stefania BonaccorsoFabrizio Schifano
Dec 31, 2020·International Journal of Molecular Sciences·Joanna Agnieszka Komorowska-Müller, Anne-Caroline Schmöle
Feb 23, 2021·Frontiers in Pharmacology·Franciele F ScaranteAlline C Campos
Mar 31, 2021·Drug and Alcohol Review·L Cinnamon BidwellHollis C Karoly
Mar 30, 2021·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·David MingleMohamed A Ibrahim
Apr 13, 2021·Neuropharmacology·Samuel S DuffyGila Moalem-Taylor
May 19, 2021·Acta Neuropathologica Communications·M Galán-GangaI Lastres-Becker
Aug 21, 2021·Scientific Reports·Joanna Agnieszka Komorowska-MüllerBritta Schürmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Cannabis & Cognition

The effect of cannabis on cognitive functioning is being explored for short and long-term effects. Recent studies have shown conflicting results, with some showing no significant effects and others showing neuropsychological impairment. Discover the latest research on cannabis and cognition here.